ribavirin has been researched along with Thyroid Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, X; Li, L; Liu, D; Shen, X; Xiao, B; Xiao, Z; Zhu, Y | 1 |
1 other study(ies) available for ribavirin and Thyroid Neoplasms
| Article | Year |
|---|---|
Antiviral Drug Ribavirin Targets Thyroid Cancer Cells by Inhibiting the eIF4E-β-Catenin Axis.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antiviral Agents; Apoptosis; beta Catenin; Cell Line, Tumor; Cell Proliferation; Humans; Mice; Mice, SCID; Paclitaxel; Ribavirin; Signal Transduction; Thyroid Neoplasms; Xenograft Model Antitumor Assays | 2017 |